We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+22.31%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$377M
AUM Growth
+$70.4M
Cap. Flow
+$26.2M
Cap. Flow %
6.95%
Top 10 Hldgs %
20.2%
Holding
148
New
51
Increased
39
Reduced
23
Closed
35

Top Sells

Rank Stock Value
1
MRCY icon
Mercury Systems
MRCY
+$9.02M
2
SLAB icon
Silicon Laboratories
SLAB
+$6.96M
3
HAE icon
Haemonetics
HAE
+$6.73M
4
AIN icon
Albany International
AIN
+$5.96M
5
LGIH icon
LGI Homes
LGIH
+$5.96M

Sector Composition

Rank Sector Weight
1 Healthcare 25.53%
2 Technology 23.63%
3 Consumer Discretionary 17.44%
4 Industrials 15.68%
5 Financials 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIN icon
26
First Financial Bankshares
FFIN
$5.04B
$5.47M 1.45%
+155,777
New +$5.36M
ACAD icon
27
Acadia Pharmaceuticals
ACAD
$4.43B
$5.24M 1.39%
122,551
+15,026
+14% +$654K
MTZ icon
28
MasTec
MTZ
$21.1B
$5.04M 1.34%
78,470
-81,765
-51% -$5.38M
FORM icon
29
FormFactor
FORM
$8.28B
$5.01M 1.33%
192,742
+80,807
+72% +$1.82M
SUM
30
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$4.96M 1.32%
+211,127
New +$4.79M
BLDR icon
31
Builders FirstSource
BLDR
$7.15B
$4.81M 1.28%
+189,160
New +$4.52M
PCTY icon
32
Paylocity
PCTY
$7.38B
$4.8M 1.27%
+39,765
New +$4.36M
PCRX icon
33
Pacira BioSciences
PCRX
$1.04B
$4.67M 1.24%
103,149
+7,779
+8% +$330K
KRNT icon
34
Kornit Digital
KRNT
$705M
$4.61M 1.22%
134,696
+1,861
+1% +$61.7K
WKC icon
35
World Kinect Corp
WKC
$2.04B
$4.31M 1.14%
+99,294
New +$4.15M
BLD
36
DELISTED
TopBuild
BLD
$4.22M 1.12%
40,920
-52,315
-56% -$5.44M
KNSL icon
37
Kinsale Capital Group
KNSL
$8.12B
$4M 1.06%
39,392
-40,965
-51% -$4.08M
LITE icon
38
Lumentum
LITE
$55.5B
$3.98M 1.06%
+50,235
New +$3.29M
LSCC icon
39
Lattice Semiconductor
LSCC
$17.6B
$3.98M 1.05%
207,771
-46,029
-18% -$884K
TNDM icon
40
Tandem Diabetes Care
TNDM
$1.34B
$3.8M 1.01%
63,767
-23,668
-27% -$1.46M
MTSI icon
41
MACOM Technology Solutions
MTSI
$19.2B
$3.79M 1%
+142,367
New +$3.4M
PEN icon
42
Penumbra
PEN
$12.7B
$3.74M 0.99%
22,774
+6,979
+44% +$1.11M
PZZA icon
43
Papa John's
PZZA
$984M
$3.73M 0.99%
+59,097
New +$3.5M
INGN icon
44
Inogen
INGN
$175M
$3.73M 0.99%
54,603
+39,083
+252% +$2.45M
NVRO
45
DELISTED
NEVRO CORP.
NVRO
$3.64M 0.97%
30,974
+16,519
+114% +$1.64M
ABCB icon
46
Ameris Bancorp
ABCB
$5.85B
$3.63M 0.96%
+85,245
New +$3.64M
TREX icon
47
Trex
TREX
$4.51B
$3.62M 0.96%
80,440
-64,350
-44% -$2.83M
CHGG icon
48
Chegg
CHGG
$110M
$3.6M 0.95%
+94,860
New +$3.32M
INSP icon
49
Inspire Medical Systems
INSP
$1.45B
$3.44M 0.91%
+46,300
New +$2.98M
CLH icon
50
Clean Harbors
CLH
$16.5B
$3.38M 0.9%
+39,420
New +$3.2M

Similar funds

Lisanti Capital Growth's Q4 2019 Portfolio in Review

As of Q4 2019, Lisanti Capital Growth held 148 positions worth $377M, up 23% from $307M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth deployed $26.2M of net new capital in Q4 2019, opening 51 new positions and adding to 39 existing holdings. Its largest new stake was Amedisys: 48,997 shares worth $8.18M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was TopBuild, an estimated $5.44M trimmed.

  • Lisanti Capital Growth's largest Q4 2019 buy was Amedisys: 48,997 shares worth $8.18M.
  • Lisanti Capital Growth added most to Planet Fitness in Q4 2019, an estimated $4.19M increase.
  • Lisanti Capital Growth's biggest Q4 2019 reduction was TopBuild, cutting an estimated $5.44M.
  • Lisanti Capital Growth fully exited Mercury Systems in Q4 2019, selling an estimated $9.02M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $377M portfolio in Q4 2019.
  • Lisanti Capital Growth opened 51 new positions and closed 35 in Q4 2019.
  • Lisanti Capital Growth's portfolio value rose 23% quarter-over-quarter to $377M.

Based on Lisanti Capital Growth's 13F filing for Q4 2019, filed 13 Feb 2020.